C19 Notes
General Category => C19 Notes Database => Topic started by: stog on May 10, 2020, 12:22:03 PM
-
Roche's COVID-19 antibody test receives FDA Emergency Use Authorization and is available in markets accepting the CE mark
The serology test has a specificity greater than 99.8% and sensitivity of 100% (14 Days post-PCR confirmation). The high specificity of the test is crucial to determine reliably if a person has been exposed to the virus and if the patient has developed antibodies. Roche will provide high double-digit millions of tests already in May… (Roche)
https://www.roche.com/media/releases/med-cor-2020-05-03.htm
(https://www.roche.com/media/releases/med-cor-2020-05-03.htm)
there are many antibody tests out there giving cause for alarm at present with false positives (https://www.cnn.com/2020/04/28/health/coronavirus-antibody-tests-terrible/index.html) -- perhaps allowing individuals to think they have had the virus and are thus immune, when in effect they are not.
see also this from Roche CEO https://www.cnbc.com/2020/04/22/roche-ceo-calls-some-covid-19-antibody-tests-a-disaster-and-questions-makers-ethics.html (https://www.cnbc.com/2020/04/22/roche-ceo-calls-some-covid-19-antibody-tests-a-disaster-and-questions-makers-ethics.html)
this Roche test certainly seems good but note the 14 day post-CPR